InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Viking Therapeutics, Inc.

VKTX Clue Score32
United States Fiscal year ends December CIK 0001607678 Results filed 28 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

9
Insider
Date
Role
Action
Shares
Price
Amount
Neil William Aubuchon
10 Mar 2026
Chief Commercial Officer
Buy
4,475
$33.50
$149.91K
Sarah Kathryn Rouan
31 Mar 2025
Director
Buy
1,240
$24.15
$29.94K
Matthew W Foehr
2 May 2022
Director
Buy
45,000
$2.47
$111.20K
Matthew W Foehr
10 Jun 2021
Director
Buy
20,000
$5.69
$113.80K
J Matthew Singleton
31 May 2018
Director
Buy
9,500
$9.82
$93.26K
Lawson Macartney
29 May 2018
Director
Buy
47,965
$5.22
$250.33K
Stephen W Webster
29 May 2018
Director
Buy
8,000
$5.21
$41.71K
Charles A Rowland Jr
29 May 2018
Director
Buy
30,000
$5.16
$154.80K
Matthew W Foehr
15 Nov 2016
Director
Buy
13,000
$1.21
$15.68K
Show all 125 transactions →

What was left out

Form 4 filings counted 173
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 66
Sales at will 44
Transactions with no price 0
Shares from compensation/vesting 8,612,884
Sales filed before the plan box existed 5
History held since 30 Apr 2015